Advertisement
UK markets open in 3 hours 22 minutes
  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     
  • HANG SENG

    17,335.76
    +134.49 (+0.78%)
     
  • CRUDE OIL

    82.78
    -0.03 (-0.04%)
     
  • GOLD FUTURES

    2,321.90
    -16.50 (-0.71%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,624.95
    -1,848.36 (-3.46%)
     
  • CMC Crypto 200

    1,389.34
    -34.76 (-2.44%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Glaxo's Key Drug Gains Time as FDA Denies Novartis Generic

Glaxo's Key Drug Gains Time as FDA Denies Novartis Generic

GlaxoSmithKline Plc’s asthma drug Advair won some room to run as U.S. regulators denied approval to rival Novartis AG’s generic version of the blockbuster treatment.